30
Participants
Start Date
March 31, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
OPL-CCL2-LPM
"CCL2-LPM~intravenous 0.001 mg/kg, 0.01 mg/kg, 0.05 mg/kg, 0.1 mg/kg, 0.5 mg/kg, 1 mg/kg~2 doses one week apart"
Eastern Health, HSC, Memorial University, St. John's
Sunnybrook Health Sciences Centre, Toronto
Hoptial Maisonneuve-Rosemont, Montreal
Lead Sponsor
Osprey Pharmaceuticals USA, Inc.
INDUSTRY